background sexual dysfunction sd is an important underestimated adverse effect of antidepressant drugspatients in fact if not directly questioned tend to scarcely report themthe aim of the present metaanalysis was to quantify sd caused by antidepressants on the basis of studies where sexual functioning was purposely investigated through direct inquiry and specific questionnairesmethods a literature search was conducted using medline isi web of knowledge and references of selected articlesselected studies performed on patients without previous sd were entered in the cochrane collaboration review manager revman version 42our primary outcome measure was the rate of total treatmentemergent sdour secondary outcome measures were the rates of treatmentemergent desire arousal and orgasm dysfunctionresults our analyses indicated a significantly higher rate of total and specific treatmentemergent sd and specific phases of dysfunction compared with placebo for the following drugs in decreasing order of impact sertraline venlafaxine citalopram paroxetine fluoxetine imipramine phenelzine duloxetine escitalopram and fluvoxamine with sd ranging from 258 to 803 of patientsno significant difference with placebo was found for the following antidepressants agomelatine amineptine bupropion moclobemide mirtazapine and nefazodonediscussion treatmentemergent sd caused by antidepressants is a considerable issue with a large variation across compoundssome assumptions such as the inclusion of openlabel studies or differences in scales used to assess sd could reduce the significance of our findingshowever treatmentemergent sd is a frequent adverse effect that should be considered in clinical activity for the choice of the prescribed drug